Vendor Analysis
published on May 20, 2024
Report Overview:
This NelsonHall vendor assessment analyzes DXC Technology's offerings and capabilities in Healthcare Payer Operations Transformation
Who is this Report for:
NelsonHall’s Healthcare Payer Operations Transformation profile on DXC Technology is a comprehensive assessment of DXC Technology's offerings and capabilities, designed for:
- Sourcing managers monitoring the capabilities of existing suppliers of DXC and identifying vendor suitability for Healthcare Payer Operations Transformation RFPs
- Vendor marketing, sales, and business managers looking to benchmark themselves against their peers
- Financial analysts and investors specializing in the Healthcare Payer Operations Transformation sector.
Scope of this Report:
The report provides a comprehensive and objective analysis of DXC Technology’s Healthcare Payer Operations Transformation offerings, capabilities, and market and financial strengths, including:
- Identification of the company’s strategy, emphasis, and new developments
- Analysis of the company’s strengths, challenges, and outlook
- Revenue estimates
- Analysis of the profile of the company’s customer base, including the company’s targeting strategy and examples of current contracts
- Analysis of the company’s offerings and key service components
- Analysis of the company’s delivery organization, including the location of delivery centers.
Key Findings & Highlights:
DXC Technology (DXC) is a global IT services company that provides business process outsourcing, analytics, engineering, applications, security, cloud, and IT outsourcing, headquartered in Ashburn, VA, U.S. DXC offers industry services across various domains, including aerospace and defense, automotive, banking, capital markets, consumer and retail, energy, utilities, oil and gas, healthcare, insurance, life sciences, manufacturing, public sector, technology, media and telecommunications, travel, transportation, and hospitality. Overall, DXC has ~1,900 clients globally with a net revenue of ~$14.4bn for FY 2023 ending in May 2023. DXC has ~130,000 employees and operates out of delivery centers in ~100 countries across North America, EMEA, APAC, and LATAM regions. DXC’s healthcare and life sciences business covers life sciences, health payers, providers, and digital health/medical technology companies. Healthcare is the second largest industry to which DXC provides services.